Area of research
Neurology · Cancer Research
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Breast Cancer Treatment Studies, and Alzheimer's disease research and treatments.
Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson’s disease: a systematic review and meta-analysis
Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes
Bidirectional regulation of levodopa-induced dyskinesia by a specific neural ensemble in globus pallidus external segment
18F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy
Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson’s disease
Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
Differential diagnosis of parkinsonism based on deep metabolic imaging indices
Predicting the risk of axillary lymph node metastasis in early breast cancer patients based on ultrasonographic-clinicopathologic features and the use of nomograms: a prospective single-center observational study
The Frontal and Cerebellar Metabolism Related to Cognitive Dysfunction in Multiple System Atrophy
Clinical Utility of <scp><sup>18</sup>F‐APN</scp>‐1607 Tau <scp>PET</scp> Imaging in Patients with Progressive Supranuclear Palsy
Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy
A new nomogram for predicting the malignant diagnosis of Breast Imaging Reporting and Data System (BI-RADS) ultrasonography category 4A lesions in women with dense breast tissue in the diagnostic setting
Propagated α-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies
Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson’s Disease by Autophagy Activation
Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta‐analysis of prospective cohort studies
Clinical, Dopaminergic, and Metabolic Correlations in Parkinson Disease
Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in <sup>18</sup>F‐FDG PET imaging
Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
Associations between cognitive impairment and motor dysfunction in Parkinson's disease
Evaluation of PDQ-8 and its relationship with PDQ-39 in China: a three-year longitudinal study
Objective and quantitative assessment of motor function in Parkinson’s disease—from the perspective of practical applications
Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease
Effect of Trehalose on PC12 Cells Overexpressing Wild-Type or A53T Mutant α-synuclein